{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:24:44Z","timestamp":1790738684751,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.2215\/cjn.05840513","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T21:38:35Z","timestamp":1386279515000},"page":"344-353","source":"Crossref","is-referenced-by-count":146,"title":["Disordered FGF23 and Mineral Metabolism in Children with CKD"],"prefix":"10.2215","volume":"9","author":[{"given":"Anthony A.","family":"Portale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Messinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wesseling-Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Warady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20230601","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa031643","article-title":"Long-term survival of children with end-stage renal disease.","volume":"350","author":"McDonald","year":"2004","journal-title":"N Engl J Med"},{"key":"R2-19-20230601","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.","volume":"67","author":"Pitts","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-19-20230601","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease.","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"R4-19-20230601","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ki.1982.70","article-title":"Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency.","volume":"21","author":"Portale","year":"1982","journal-title":"Kidney Int"},{"key":"R5-19-20230601","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","article-title":"The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.","volume":"95","author":"Bacchetta","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-19-20230601","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R7-19-20230601","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R8-19-20230601","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1\u03b1,25-dihydroxyvitamin D3 production.","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"key":"R9-19-20230601","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R10-19-20230601","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.","volume":"293","author":"Perwad","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R11-19-20230601","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study.","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R12-19-20230601","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.10331011","article-title":"FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.","volume":"7","author":"Lundberg","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-19-20230601","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and CKD progression in African Americans.","volume":"24","author":"Scialla","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R14-19-20230601","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"key":"R15-19-20230601","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R16-19-20230601","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R17-19-20230601","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"R18-19-20230601","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2010.107","article-title":"Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.","volume":"78","author":"van Husen","year":"2010","journal-title":"Kidney Int"},{"key":"R19-19-20230601","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00467-011-1870-5","article-title":"Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease.","volume":"26","author":"Siomou","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R20-19-20230601","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"R21-19-20230601","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1093\/ndt\/gfs109","article-title":"Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3-5.","volume":"27","author":"Sinha","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R22-19-20230601","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease.","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-19-20230601","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2215\/CJN.01941205","article-title":"Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.","volume":"1","author":"Furth","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-19-20230601","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"R25-19-20230601","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.ki.5000385","article-title":"Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children.","volume":"69","author":"Schwartz","year":"2006","journal-title":"Kidney Int"},{"key":"R26-19-20230601","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ki.2012.169","article-title":"Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.","volume":"82","author":"Schwartz","year":"2012","journal-title":"Kidney Int"},{"key":"R27-19-20230601","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1258\/acb.2012.011274","article-title":"Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase.","volume":"49","author":"Fischer","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"R28-19-20230601","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.clinbiochem.2009.07.013","article-title":"An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D.","volume":"42","author":"Wagner","year":"2009","journal-title":"Clin Biochem"},{"key":"R29-19-20230601","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.clinbiochem.2004.06.006","article-title":"Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer.","volume":"37","author":"Ersfeld","year":"2004","journal-title":"Clin Biochem"},{"key":"R30-19-20230601","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinchem\/42.4.586","article-title":"Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer.","volume":"42","author":"Hollis","year":"1996","journal-title":"Clin Chem"},{"key":"R31-19-20230601","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/clinchem\/34.8.1625","article-title":"Age- and sex-specific pediatric reference intervals and correlations for zinc, copper, selenium, iron, vitamins A and E, and related proteins.","volume":"34","author":"Lockitch","year":"1988","journal-title":"Clin Chem"},{"key":"R33-19-20230601","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R34-19-20230601","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ki.1985.48","article-title":"Altered divalent ion metabolism in early renal failure: Role of 1,25(OH)2D.","volume":"27","author":"Wilson","year":"1985","journal-title":"Kidney Int"},{"key":"R35-19-20230601","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"R36-19-20230601","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ki.2010.375","article-title":"Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.","volume":"79","author":"Pavik","year":"2011","journal-title":"Kidney Int"},{"key":"R37-19-20230601","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"R38-19-20230601","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archpedi.162.6.505","article-title":"Prevalence of vitamin D deficiency among healthy infants and toddlers.","volume":"162","author":"Gordon","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R39-19-20230601","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1542\/peds.2009-0051","article-title":"Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004.","volume":"124","author":"Kumar","year":"2009","journal-title":"Pediatrics"},{"key":"R40-19-20230601","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s00467-010-1612-0","article-title":"Vitamin D deficiency and parathyroid hormone levels following renal transplantation in children.","volume":"25","author":"Tuchman","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R41-19-20230601","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00467-008-0842-x","article-title":"Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease.","volume":"23","author":"Menon","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R42-19-20230601","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s00467-010-1639-2","article-title":"Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease.","volume":"25","author":"Hari","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R43-19-20230601","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ki.2011.431","article-title":"Vitamin D deficiency is common in children and adolescents with chronic kidney disease.","volume":"81","author":"Kalkwarf","year":"2012","journal-title":"Kidney Int"},{"key":"R44-19-20230601","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2215\/CJN.07100810","article-title":"Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease.","volume":"6","author":"Furth","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R45-19-20230601","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.ajkd.2010.12.027","article-title":"Role of Klotho in aging, phosphate metabolism, and CKD.","volume":"58","author":"John","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R46-19-20230601","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ndt\/gfs411","article-title":"Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.","volume":"28","author":"Wan","year":"2013","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201402000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:58Z","timestamp":1786369438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201402000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.05840513","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}